Fabio Fuligni

6.9k total citations · 1 hit paper
35 papers, 1.1k citations indexed

About

Fabio Fuligni is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Fabio Fuligni has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 12 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Fabio Fuligni's work include Lymphoma Diagnosis and Treatment (12 papers), Immune Cell Function and Interaction (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Fabio Fuligni is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Immune Cell Function and Interaction (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Fabio Fuligni collaborates with scholars based in Italy, Canada and United States. Fabio Fuligni's co-authors include Clelia Peano, Gianluca De Bellis, Marcus J. Claesson, Deirdre M. Murray, Abelardo Margollés, Francesca Turroni, Miguel Gueimonde, Colm Kerr, Jonathan Hourihane and Douwe van Sinderen and has published in prestigious journals such as Blood, PLoS ONE and Science Advances.

In The Last Decade

Fabio Fuligni

34 papers receiving 1.1k citations

Hit Papers

Diversity of Bifidobacteria within the Infant Gut Microbiota 2012 2026 2016 2021 2012 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabio Fuligni Italy 16 641 241 233 221 210 35 1.1k
Rick de Waard Netherlands 9 311 0.5× 148 0.6× 492 2.1× 213 1.0× 204 1.0× 9 1.1k
Lars Helgeland Norway 20 238 0.4× 77 0.3× 320 1.4× 135 0.6× 98 0.5× 46 1.0k
Chad Storer United States 12 516 0.8× 48 0.2× 414 1.8× 259 1.2× 76 0.4× 18 1.5k
Melania Scarpa Italy 20 450 0.7× 71 0.3× 573 2.5× 206 0.9× 68 0.3× 53 1.4k
Thorbjørn Krejsgaard Denmark 29 530 0.8× 82 0.3× 1.0k 4.4× 440 2.0× 626 3.0× 46 2.2k
Matija Rijavec Slovenia 23 381 0.6× 68 0.3× 401 1.7× 109 0.5× 55 0.3× 73 1.4k
Montserrat Cols United States 18 453 0.7× 62 0.3× 1.2k 5.2× 127 0.6× 116 0.6× 26 1.9k
Samuel Lundin Sweden 22 523 0.8× 58 0.2× 916 3.9× 164 0.7× 45 0.2× 41 1.7k
Lucia M. Kato Japan 9 613 1.0× 82 0.3× 560 2.4× 130 0.6× 36 0.2× 9 1.1k

Countries citing papers authored by Fabio Fuligni

Since Specialization
Citations

This map shows the geographic impact of Fabio Fuligni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Fuligni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Fuligni more than expected).

Fields of papers citing papers by Fabio Fuligni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio Fuligni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Fuligni. The network helps show where Fabio Fuligni may publish in the future.

Co-authorship network of co-authors of Fabio Fuligni

This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Fuligni. A scholar is included among the top collaborators of Fabio Fuligni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio Fuligni. Fabio Fuligni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Visani, Giuseppe, Maryam Etebari, Fabio Fuligni, et al.. (2023). Use of Next Generation Sequencing to Define the Origin of Primary Myelofibrosis. Cancers. 15(6). 1785–1785. 1 indexed citations
2.
Pileri, Alessandro, et al.. (2021). Second neoplasm in cutaneous T-cell lymphoma patients: a marker of worse prognosis?. Italian Journal of Dermatology and Venereology. 156(4). 3 indexed citations
3.
Loscocco, Federica, Giuseppe Visani, Annamaria Ruzzo, et al.. (2021). Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib. Frontiers in Oncology. 11. 672287–672287. 15 indexed citations
4.
Tandon, Sneha, Mary Shago, Scott Davidson, et al.. (2020). First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia. Cancer Genetics. 248-249. 31–33. 3 indexed citations
5.
Sapienza, Maria Rosaria, Fabio Fuligni, Federica Melle, et al.. (2020). MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma. Hematological Oncology. 38(5). 831–833. 2 indexed citations
6.
Visani, Giuseppe, Felicetto Ferrara, Francesco Di Raimondo, et al.. (2017). Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II study. Leukemia Research. 62. 77–83. 11 indexed citations
7.
Pizzi, Marco, Fabio Fuligni, Luisa Santoro, et al.. (2016). Spleen histology in children with sickle cell disease and hereditary spherocytosis: hints on the disease pathophysiology. Human Pathology. 60. 95–103. 16 indexed citations
8.
Hartmann, Sylvia, Claudia Döring, Claudio Agostinelli, et al.. (2016). miRNA expression profiling divides follicular dendritic cell sarcomas into two groups, related to fibroblasts and myopericytomas or Castleman's disease. European Journal of Cancer. 64. 159–166. 13 indexed citations
9.
Piccaluga, Pier Paolo, Claudio Agostinelli, Fabio Fuligni, et al.. (2015). IFI16Expression Is Related to Selected Transcription Factors during B-Cell Differentiation. Journal of Immunology Research. 2015. 1–20. 21 indexed citations
10.
Falco, Giulia De, Maria Raffaella Ambrosio, Fabio Fuligni, et al.. (2015). Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation. BMC Cancer. 15(1). 668–668. 24 indexed citations
11.
Derenzini, Enrico, Claudio Agostinelli, Ilaria Iacobucci, et al.. (2015). Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma. Oncotarget. 6(9). 6553–6569. 48 indexed citations
12.
Pantaleo, Maria A., Annalisa Astolfi, Milena Urbini, et al.. (2014). Dystrophin deregulation is associated with tumor progression in KIT/PDGFRA mutant gastrointestinal stromal tumors. PubMed. 4(1). 9–9. 9 indexed citations
13.
Peano, Clelia, Fabrizio Damiano, Mattia Forcato, et al.. (2014). Comparative genomics revealed key molecular targets to rapidly convert a reference rifamycin-producing bacterial strain into an overproducer by genetic engineering. Metabolic Engineering. 26. 1–16. 27 indexed citations
14.
Mannu, Claudia, Anna Gazzola, Elena Ciabatti, et al.. (2014). Comparison of different DNA extraction methods from peripheral blood cells: advice from the Fondazione Italiana Linfomi Minimal Residual Disease Network. Leukemia & lymphoma. 57(2). 400–410. 3 indexed citations
15.
Fondi, Marco, Valerio Orlandini, Giorgio Corti, et al.. (2014). Enly: Improving Draft Genomes through Reads Recycling. PubMed. 2. 89–93. 2 indexed citations
16.
Navari, Mohsen, Fabio Fuligni, Maria Antonella Laginestra, et al.. (2014). Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus. Frontiers in Microbiology. 5. 728–728. 23 indexed citations
17.
Agostinelli, Claudio, Hasan Rizvi, Jennifer C. Paterson, et al.. (2014). Intracellular TCR-signaling Pathway. The American Journal of Surgical Pathology. 38(10). 1349–1359. 16 indexed citations
18.
Sangaletti, Sabina, Claudio Tripodo, Caterina Vitali, et al.. (2013). Defective Stromal Remodeling and Neutrophil Extracellular Traps in Lymphoid Tissues Favor the Transition from Autoimmunity to Lymphoma. Cancer Discovery. 4(1). 110–129. 90 indexed citations
19.
Rossi, Maura, Fabio Fuligni, Maria Ciccone, et al.. (2013). Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia. BioMed Research International. 2013. 1–13. 8 indexed citations
20.
Turroni, Francesca, Clelia Peano, Daniel A. Pass, et al.. (2012). Diversity of Bifidobacteria within the Infant Gut Microbiota. PLoS ONE. 7(5). e36957–e36957. 502 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026